Global Market of Narcolepsy Drug Developed rapidly, with an average Growth rate of 9.6%. In 2016, global revenue of narcolepsy drug is nearly 1725 M USD

Description :

In the last several years, global market of narcolepsy drug developed rapidly, with an average growth rate of 9.6%. In 2016, global revenue of narcolepsy drug is nearly 1725 M USD; the actual production is about 48380 Kg.
 
The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
 
The classification of narcolepsy drug includes antioxidants type, stimulants type and other types, and the proportion of antioxidants type in 2016 is about 78% in the world.
 
Narcolepsy drug is widely used for daytime extreme sleepiness, cataplexia and other field. The most proportion of narcolepsy drug is used for cataplexia, and the consumption proportion in 2016 is about 57%.
 
Europe region is the largest supplier of narcolepsy drug, with a production market share nearly 79% in 2016. USA is the second largest supplier of narcolepsy drug, enjoying production market share nearly 12% in 2015.
 
Europe is the largest consumption place, with a consumption market share nearly 58% in 2015. Following Europe, USA is the second largest consumption place with the consumption market share of 29%.
 
Market competition is concentrated. Jazz Pharmaceuticals, Teva Pharmaceutical, Novartis and Mylan. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

 

 

 
The report is readily available and can be dispatched immediately after payment confirmation.
 
Buy this premium research report - http://globalqyresearch.com/checkout-form/0/191772
 
Would like to place an order or any question, please feel free to contact at sales@globalqyresearch.com | +44 2032 392407
 
 

Copyright © 2018 Global QY Research